The Cole Center for Healing

04/29/2026

The technical issues have finally been fixed.....at least for now. Having had two TBIs myself and having treated TBI for many years, I know what I'd like to include in the course. But I would like to know what YOU would like to be contained in the course. Please click the link below and let me know you're thoughts about what information should be included.

https://docs.google.com/forms/d/e/1FAIpQLSc5pruRwE7l65IPRYTIpMgzQTuZ1kaG9-YaZINQjvVEJ3BmuQ/viewform?usp=header

04/25/2026

Neurodegenerative diseases (NDs) encompass all disorders that affect both the central and peripheral nervous systems and are widespread worldwide. NDs lack effective treatments or cures and represent major challenges in public health.

It was found that patients with significant loads of toxic metals (TMs) were all affected by ND, and that their severe symptoms were correlated with the severity of intoxication. It was also shown that chelation therapies with ethylenediaminetetraacetic acid (CaNa2EDTA) (hereafter EDTA) are effective in eliminating the burden of TMs in humans, and that EDTA has many other important functions, including antioxidant and anti-inflammatory properties and improvement of diabetes and it's complications.

Chelation therapy has been found to improve neurodegenerative diseases and many other conditions.

Maria Elena Ferrero. Neuron Protection by EDTA May Explain the Successful Outcomes of Toxic Metal Chelation Therapy in Neurodegenerative Diseases. Biomedicines 2022, 10(10), 2476; https://doi.org/10.3390/biomedicines10102476

04/19/2026

Hyperbaric Oxygen Therapy has been part of our cancer program for many years. This study again supports that use: It has been demonstrated that HBOT has considerable effects on carcinoma, especially on decreasing complications and improving mortality.

In addition, the authors go on to state that hey have confirmed that HBOT for curing prostate cancer is clinically significant.

Lu QZ, Li X, Ouyang J, Li JQ, Chen G. Further application of hyperbaric oxygen in prostate cancer. Med Gas Res. 2019 Jan 9;8(4):167-171. doi: 10.4103/2045-9912.248268. PMID: 30713670; PMCID: PMC6352573.

04/19/2026

Hyperbaric Oxygen Therapy has been part of our cancer program for many years. This study again supports that use:

It has been demonstrated that HBOT has considerable effects on carcinoma, especially on decreasing complications and improving mortality.

In addition, the authors go on to state that hey have confirmed that HBOT for curing prostate cancer is clinically significant.

If you're looking for information about ways to address cancer from an integrative approach, call us at 513-563-4321 for more info.

Lu QZ, Li X, Ouyang J, Li JQ, Chen G. Further application of hyperbaric oxygen in prostate cancer. Med Gas Res. 2019 Jan 9;8(4):167-171. doi: 10.4103/2045-9912.248268. PMID: 30713670; PMCID: PMC6352573.

04/17/2026

Here are some of the things you can do:

• Switch to glass, stainless steel, or ceramic for food storage and water bottles

• Never heat food in plastic containers, as heat accelerates plastic breakdown and particle release

• Filter your tap water (which typically has fewer microplastics than bottled water)

• Reduce packaged and processed foods; buy whole foods and cook at home

• Limit shellfish consumption if microplastic exposure is a concern for your family

• Choose natural fiber clothing (wool, cotton, linen) over synthetic fabrics

• Vacuum and ventilate your home regularly, as household dust is a significant indoor source

• For infants: use glass bottles, minimize plastic teats, and avoid plastic teething toys

At The Cole Center, we can develop a program for you to help detox these microplastics. Call us at 513-563-4321 for more info.

04/17/2026

Microplastics are a real and pervasive issue. Here's some of the problems they cause:

Patients with microplastics in their arterial plaque had a significantly higher risk of heart attack, stroke, and death. (New England Journal of Medicine, 2024)

Beyond cardiovascular disease, the research points to a troubling array of potential harms:

• Chronic inflammation, the root driver of most modern disease

• Oxidative stress and DNA damage at the cellular level

• Disruption of the gut microbiome

• Hormonal and endocrine disruption, linked to reproductive disorders

• Immune system suppression and dysregulation

• Elevated cancer risk, particularly colon and lung cancer

• Possible neurotoxicity and contribution to neurological conditions

See the next post!

04/01/2026

'm thinking of producing some educational courses on medical topics. What are the main topics you would like to see covered?

Call now to connect with business.

04/01/2026

I get questions about the shingles vaccine, so here's info from the studies: Only 3.5 out of 100 unvaccinated people in this age group developed shingles over roughly three years. That means 96.5 out of 100 would not have gotten shingles anyway, with or without the vaccine.

“97% effective” means the vaccine reduced the rate among those who would have gotten shingles. It does not mean 97 in 100 vaccinated people are protected from something that would otherwise have happened to them.

The absolute benefit, the actual reduction in cases attributable to vaccination, was about 3.4 cases prevented per 100 people vaccinated over three years. That translates to a “number needed to treat” (NNT) of approximately 30 people you need to vaccinate in this age group to prevent one case of shingles over a three-year period.

In the trials, 78 to 84 percent of vaccinated people reported at least one reaction within 7 days, compared with about 30 percent in the placebo group. Most were mild: sore arm, tiredness, headache. But a meaningful proportion were severe enough to disrupt daily life. This is measured as “grade 3” reactions — fever over 39°C, muscle pain that prevents normal activity, and injection-site pain at rest.

The “number needed to harm” (NNH) for a grade 3 reaction, meaning one serious enough to stop you doing normal things for a day or two, was:

• Ages 50–69: approximately 1 in 11 vaccinated people

• Ages 70+: approximately 1 in 25 vaccinated people

All of the clinical evidence for Shingrix, every pivotal trial, every extension study, every long-term follow-up analysis, was funded by GlaxoSmithKline, the vaccine’s manufacturer. Several named authors on the key publications were GSK employees at the time. Medical writing for the main publications was paid for by GSK. The decision about when to submit results for publication was made by GSK.

For the full description, go here:

The headline number is 97% effective. The number that actually matters to you is closer to 3%. Both are true. Here's what's going on — and why the distinction matters.

03/31/2026

The Cole Center for Healing is a family, practice, specializing and holistic/integrative medicine. If you have been struggling with health issues that you can’t seem to find the answer to or just want to improve your health we can help! In our practice we see patients from all over the world for things from newborn baby check ups to stage four cancer

03/20/2026

More Covid vaccine news: A growing body of peer-reviewed research published between 2023 and 2025 documents that repeated mRNA boosting causes a progressive shift in the type of antibody your immune system produces against the virus. This shift is not random noise. It follows a well-understood biological pattern. And it has measurable, functional consequences.

1. Increased risk of breakthrough COVID infection

Martín Pérez et al. (2025) found that healthcare workers who developed the IgG4 shift were more likely to get COVID afterward. This is the first published study to link the antibody shift to an actual adverse health outcome. It needs replication, but the direction is predicted by the biology.

2. Loss of the immune functions that clear infected cells

Kalkeri et al. (2025) directly measured the functional consequences. Higher IgG4 was correlated with reduced capacity for three distinct immune clearance mechanisms: ADCC (r = –0.53), complement deposition (r = –0.53), and phagocytosis (r = –0.40). These are not theories. They are published measurements.

3. The damage is written into immune memory

Irrgang et al. (Science Immunology, 2023) found that 14.4% of the long-term immune memory cells targeting the spike protein were IgG4-producing after repeated boosting. These cells persist for years. The impairment does not fade when vaccination stops.

4. Children are also affected

Kobbe et al. (Pediatric Infectious Disease Journal, 2024) confirmed IgG4 switching in children aged 5 to 11 after only two standard pediatric doses. The effect is not limited to adults who received many boosters.

For the complete explanation, go to:

A plain-language guide to what the research now shows

03/06/2026

This is one of the scariest studies I've seen lately:

Elevated residential extremely low-frequency magnetic fields (ELF-MF) exposure, as well as prolonged tablet use, both with and without internet connectivity, were significantly associated with an increased risk of developing Central nervous system tumors (CNST) in childhood.

Sources include cell phones, towers, etc. Since everyone is exposed to these fields, I've looked for a way to minimize their effect. The only one I've found in the last several years that is reliable is by Aires. If you'd like more info or evaluation, call us at 513-563-4321. To order, go to: airestech.com/?utm_source=theodore-cole-60160&utm_medium=Ambassador60160&utm_

Víctor Correa‐Correa, et. al. Extremely low-frequency magnetic fields (ELF-MF) and radiofrequency: Risk of childhood CNS tumors in a city with elevated ELF-MF exposure,
Environmental Research, Volume 286, Part 2, 2025, 122858,
ISSN 0013-9351,
https://doi.org/10.1016/j.envres.2025.122858.

Explore Aires Tech's advanced EMF protectors for your cell phone and digital lifestyle. Shield against EMF radiation! Better than an EMF blocker.

03/06/2026